@article{Hasegawa2014,
  title     = {Sample size determination for the weighted log-rank test with the Fleming--Harrington class of weights in cancer vaccine studies},
  author    = {Hasegawa, Takahiro},
  journal   = {Pharmaceutical Statistics},
  volume    = {13},
  number    = {2},
  pages     = {128--135},
  year      = {2014},
  publisher = {Wiley Online Library}
}
@article{AHRKalbfleisch1981,
  title     = {Estimation of the average hazard ratio},
  author    = {Kalbfleisch, John D and Prentice, Ross L},
  journal   = {Biometrika},
  volume    = {68},
  number    = {1},
  pages     = {105--112},
  year      = {1981},
  publisher = {Oxford University Press}
}
@article{AHRRauch2018,
  title     = {The Average Hazard Ratio---A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?},
  author    = {Rauch, Geraldine and Brannath, Werner and Br{\"u}ckner, Matthias and Kieser, Meinhard},
  journal   = {Methods of Information in Medicine},
  volume    = {57},
  number    = {03},
  pages     = {89--100},
  year      = {2018},
  publisher = {Schattauer GmbH}
}
@article{AHRSchemper2009,
  title     = {The estimation of average hazard ratios by weighted Cox regression},
  author    = {Schemper, Michael and Wakounig, Samo and Heinze, Georg},
  journal   = {Statistics in Medicine},
  volume    = {28},
  number    = {19},
  pages     = {2473--2489},
  year      = {2009},
  publisher = {Wiley Online Library}
}
@article{Hasegawa2016,
  title   = {"Group sequential monitoring based on the weighted log-rank test statistic with the Fleming--Harrington class of weights in cancer vaccine studies"},
  author  = {Hasegawa, Takahiro},
  journal = {Pharmaceutical Statistics},
  volume  = {15},
  number  = {5},
  pages   = {412--419},
  year    = {2016}
}
@article{FHRhoGamma,
  title     = {A class of rank test procedures for censored survival data},
  author    = {Harrington, David P and Fleming, Thomas R},
  journal   = {Biometrika},
  volume    = {69},
  number    = {3},
  pages     = {553--566},
  year      = {1982},
  publisher = {Oxford University Press}
}
@article{Lakatos,
  author  = {Lakatos, Edward},
  title   = {Sample size based on the log-rank statistic in complex clinical trials},
  journal = {Biometrics},
  volume  = {44},
  year    = {1988},
  pages   = {229-241}
}
@article{Cox1972,
  author  = {David R. Cox},
  title   = {Regression models and life-tables},
  journal = {Journal of the Royal Statistics Society, Series B},
  volume  = {34},
  year    = {1972},
  pages   = {187-220}
}
@article{petologrank,
  title     = {Asymptotically efficient rank invariant test procedures},
  author    = {Peto, Richard and Peto, Julian},
  journal   = {Journal of the Royal Statistical Society. Series A (General)},
  pages     = {185--207},
  year      = {1972},
  publisher = {JSTOR}
}
@article{peto1977design,
  title={Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples},
  author={Peto, Richard and Pike, MCetal and Armitage, Philip and Breslow, Norman E and Cox, DR and Howard, SV and Mantel, N and McPherson, K and Peto, J and Smith, PG},
  journal={British journal of cancer},
  volume={35},
  number={1},
  pages={1--39},
  year={1977},
  publisher={Nature Publishing Group}
}
@article{KaplanMeier,
  author    = {E. L.   Kaplan  and  Paul   Meier},
  title     = {Nonparametric Estimation from Incomplete Observations},
  journal   = {Journal of the American Statistical Association},
  volume    = {53},
  number    = {282},
  pages     = {457-481},
  year      = {1958},
  publisher = {Taylor & Francis},
  doi       = {10.1080/01621459.1958.10501452},
  url       = {https://www.tandfonline.com/doi/abs/10.1080/01621459.1958.10501452},
  eprint    = {https://www.tandfonline.com/doi/pdf/10.1080/01621459.1958.10501452}
}
@article{Karrison2016,
  title     = {Versatile tests for comparing survival curves based on weighted log-rank statistics},
  author    = {Karrison, Theodore G and others},
  journal   = {Stata Journal},
  volume    = {16},
  number    = {3},
  pages     = {678--690},
  year      = {2016},
  publisher = {StataCorp LP}
}

@article{Schemper1992,
  title     = {Cox analysis of survival data with non-proportional hazard functions},
  author    = {Schemper, Michael},
  journal   = {The Statistician},
  pages     = {455--465},
  year      = {1992},
  publisher = {JSTOR}
}
@article{ewell1997large,
  title     = {The large sample distribution of the weighted log rank statistic under general local alternatives},
  author    = {Ewell, Marian and Ibrahim, Joseph G},
  journal   = {Lifetime Data Analysis},
  volume    = {3},
  number    = {1},
  pages     = {5--12},
  year      = {1997},
  publisher = {Springer}
}
@article{gray1989linear,
  title     = {A linear rank test for use when the main interest is in differences in cure rates},
  author    = {Gray, Robert J and Tsiatis, Anastasios A},
  journal   = {Biometrics},
  pages     = {899--904},
  year      = {1989},
  publisher = {JSTOR}
}
@article{wu2017sample,
  title     = {Sample size calculation for testing differences between cure rates with the optimal log-rank test},
  author    = {Wu, Jianrong},
  journal   = {Journal of Biopharmaceutical Statistics},
  volume    = {27},
  number    = {1},
  pages     = {124--134},
  year      = {2017},
  publisher = {Taylor \& Francis}
}
@article{LachinFoulkes,
  author  = {Lachin, John M. and Foulkes, Mary A.},
  title   = {Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification},
  journal = {Biometrics},
  volume  = {42},
  year    = {1986},
  pages   = {507-519}
}
@article{Schoenfeld1981,
  title     = {The asymptotic properties of nonparametric tests for comparing survival distributions},
  author    = {Schoenfeld, David},
  journal   = {Biometrika},
  volume    = {68},
  number    = {1},
  pages     = {316--319},
  year      = {1981},
  publisher = {Oxford University Press}
}
@article{Schoenfeld1982,
  title     = {Partial residuals for the proportional hazards regression model},
  author    = {Schoenfeld, David},
  journal   = {Biometrika},
  volume    = {69},
  number    = {1},
  pages     = {239--241},
  year      = {1982},
  publisher = {Oxford University Press}
}
@article{Mukhopadhyay2020,
  title     = {Statistical and practical considerations in designing of immuno-oncology trials},
  author    = {Mukhopadhyay, Pralay and Huang, Wenmei and Metcalfe, Paul and {\"O}hrn, Fredrik and 
               Jenner, Mary and Stone, Andrew},
  journal   = {Journal of Biopharmaceutical Statistics},
  pages     = {1--17},
  year      = {2020},
  publisher = {Taylor \& Francis}
}
@article{Tsiatis,
  author  = {Anastasios A. Tsiatis},
  title   = {Repeated significance testing for a general class of statistics use in censored survival analysis},
  journal = {Journal of the American Statistical Association},
  volume  = {77},
  pages   = {855-861},
  year    = {1982}
}
@article{HRhazards2010,
  title     = {The hazards of hazard ratios},
  author    = {Hern{\'a}n, Miguel A},
  journal   = {Epidemiology},
  volume    = {21},
  number    = {1},
  pages     = {13},
  year      = {2010},
  publisher = {NIH Public Access}
}
@book{JTBook,
  author    = {Jennison, Christopher and Turnbull, Bruce W.},
  title     = {Group Sequential Methods with Applications to Clinical Trials},
  publisher = {Chapman and Hall/CRC},
  address   = {Boca Raton, FL},
  year      = {2000}
}
@misc{simtrial,
  author       = {Keaven M. Anderson},
  title        = {Clinical Trial Simulation},
  year         = {2020},
  publisher    = {Merck & Co., Inc.},
  journal      = {GitHub repository},
  howpublished = {\url{https://github.com/Merck/simtrial}}
}
@misc{gsDesign2,
  author       = {Keaven M. Anderson},
  title        = {Group Sequential Design Under Non-Proportional Hazards},
  year         = {2020},
  publisher    = {Merck & Co., Inc.},
  journal      = {GitHub repository},
  howpublished = {\url{https://github.com/Merck/gsDesign2}}
}
@misc{gsdmvn,
  author       = {Keaven M. Anderson},
  title        = {Group sequential design with non-constant effect},
  year         = {2020},
  publisher    = {Merck & Co., Inc.},
  journal      = {GitHub repository},
  howpublished = {\url{https://github.com/Merck/gsdmvn}}
}
@book{Klein2006,
  title     = {Survival analysis: techniques for censored and truncated data},
  author    = {Klein, John P and Moeschberger, Melvin L},
  year      = {2006},
  publisher = {Springer Science \& Business Media}
}
@article{Cox1972,
  title     = {Regression models and life-tables},
  author    = {Cox, David R},
  journal   = {Journal of the Royal Statistical Society: Series B (Methodological)},
  volume    = {34},
  number    = {2},
  pages     = {187--202},
  year      = {1972},
  publisher = {Wiley Online Library}
}
@article{Grambsch1994,
  title     = {Proportional hazards tests and diagnostics based on weighted residuals},
  author    = {Grambsch, Patricia M and Therneau, Terry M},
  journal   = {Biometrika},
  volume    = {81},
  number    = {3},
  pages     = {515--526},
  year      = {1994},
  publisher = {Oxford University Press}
}
@article{KEYNOTE040,
  title     = {Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study},
  author    = {Cohen, Ezra EW and Souli{\`e}res, Denis and Le Tourneau, Christophe and Dinis, Jos{\'e} and Licitra, Lisa and Ahn, Myung-Ju and Soria, Ainara and Machiels, Jean-Pascal and Mach, Nicolas and Mehra, Ranee and others},
  journal   = {The Lancet},
  volume    = {393},
  number    = {10167},
  pages     = {156--167},
  year      = {2019},
  publisher = {Elsevier}
}
@article{KEYNOTE042,
  title     = {Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial},
  author    = {Mok, Tony SK and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Cho, Byoung Chul and Turna, Hande Z and Castro Jr, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin K and Bondarenko, Igor and others},
  journal   = {The Lancet},
  volume    = {393},
  number    = {10183},
  pages     = {1819--1830},
  year      = {2019},
  publisher = {Elsevier}
}
@article{KEYNOTE061,
  title     = {Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial},
  author    = {Shitara, Kohei and {\"O}zg{\"u}ro{\u{g}}lu, Mustafa and Bang, Yung-Jue and Di Bartolomeo, Maria and Mandal{\`a}, Mario and Ryu, Min-Hee and Fornaro, Lorenzo and Olesi{\'n}ski, Tomasz and Caglevic, Christian and Chung, Hyun C and others},
  journal   = {The Lancet},
  volume    = {392},
  number    = {10142},
  pages     = {123--133},
  year      = {2018},
  publisher = {Elsevier}
}
@article{KEYNOTE189,
  title     = {Pembrolizumab plus chemotherapy in metastatic non--small-cell lung cancer},
  author    = {Gandhi, Leena and Rodr{\'\i}guez-Abreu, Delvys and Gadgeel, Shirish and Esteban, Emilio and Felip, Enriqueta and De Angelis, Fl{\'a}via and Domine, Manuel and Clingan, Philip and Hochmair, Maximilian J and Powell, Steven F and others},
  journal   = {New England Journal of Medicine},
  volume    = {378},
  number    = {22},
  pages     = {2078--2092},
  year      = {2018},
  publisher = {Mass Medical Soc}
}
@article{simva4s,
  title     = {Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)},
  author    = {Miettinen, Tatu A and Pyörälä, Kalevi and Olsson, Anders G and Musliner, Thomas A and Cook, Thomas J and Faergeman, Ole and Berg, Kåre and Pedersen, Terje and Kjekshus, John and Group, for the Scandinavian Simvastatin Study},
  journal   = {Circulation},
  volume    = {96},
  number    = {12},
  pages     = {4211--4218},
  year      = {1997},
  publisher = {Am Heart Assoc}
}
@article{LanDeMets,
  author  = {Lan, K.~K.~G. and DeMets, David L.},
  title   = {Discrete sequential boundaries for clinical trials},
  journal = {Biometrika},
  volume  = {70},
  year    = {1983},
  pages   = {659-663}
}

@article{LanDeMets1989,
  author  = {Lan, K.~K.~G. and DeMets, David L.},
  title   = {Group sequential procedures: Calendar versus information time},
  journal = {Statistics in Medicine},
  volume  = {8},
  year    = {1989},
  pages   = {1191-1198},
  doi     = {10.1002/sim.4780081003}
}
@article{KEYNOTE604,
  title     = {Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study},
  author    = {Rudin, Charles M and Awad, Mark M and Navarro, Alejandro and Gottfried, Maya and Peters, Solange and Cs{\H{o}}szi, Tibor and Cheema, Parneet K and Rodriguez-Abreu, Delvys and Wollner, Mirjana and Yang, James Chih-Hsin and others},
  journal   = {Journal of Clinical Oncology},
  volume    = {38},
  number    = {21},
  pages     = {2369--2379},
  year      = {2020},
  publisher = {American Society of Clinical Oncology}
}
@article{atezoSCLC1L,
  title     = {First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer},
  author    = {Horn, Leora and Mansfield, Aaron S and Szcz{\k{e}}sna, Aleksandra and Havel, Libor and Krzakowski, Maciej and Hochmair, Maximilian J and Huemer, Florian and Losonczy, Gy{\"o}rgy and Johnson, Melissa L and Nishio, Makoto and others},
  journal   = {New England Journal of Medicine},
  volume    = {379},
  number    = {23},
  pages     = {2220--2229},
  year      = {2018},
  publisher = {Mass Medical Soc}
}
@article{Ye2013,
  title     = {A group sequential Holm procedure with multiple primary endpoints},
  author    = {Ye, Yining and Li, Ai and Liu, Lingyun and Yao, Bin},
  journal   = {Statistics in Medicine},
  volume    = {32},
  number    = {7},
  pages     = {1112--1124},
  year      = {2013},
  publisher = {Wiley Online Library}
}
@article{MaurerBretz2013,
  author  = {Willi Maurer and Frank Bretz},
  title   = {Multiple testing in group sequential trials using graphical approaches},
  journal = {Statistics in Biopharmaceutical Research},
  volume  = {5},
  year    = {2013},
  pages   = {311-320},
  doi     = {10.1080/19466315.2013.807748}
}

@article{KEYNOTE048,
  title     = {Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study},
  author    = {Burtness, Barbara and Harrington, Kevin J and Greil, Richard and Souli{\`e}res, Denis and Tahara, Makoto and de Castro Jr, Gilberto and Psyrri, Amanda and Bast{\'e}, Neus and Neupane, Prakash and Bratland, {\AA}se and others},
  journal   = {The Lancet},
  volume    = {394},
  number    = {10212},
  pages     = {1915--1928},
  year      = {2019},
  publisher = {Elsevier}
}
@article{Follmann1994MAMS,
  title     = {Monitoring pairwise comparisons in multi-armed clinical trials},
  author    = {Follmann, Dean A and Proschan, Michael A and Geller, Nancy L},
  journal   = {Biometrics},
  pages     = {325--336},
  year      = {1994},
  publisher = {JSTOR}
}
@article{YungLiu,
  title     = {Sample size and power for the weighted log-rank test and Kaplan-Meier based tests with allowance for nonproportional hazards},
  author    = {Yung, Godwin and Liu, Yi},
  journal   = {Biometrics},
  volume    = {76},
  number    = {3},
  pages     = {939--950},
  year      = {2020},
  publisher = {Wiley Online Library}
}
@article{MagirrBurman,
  title     = {Modestly weighted logrank tests},
  author    = {Magirr, Dominic and Burman, Carl-Fredrik},
  journal   = {Statistics in Medicine},
  volume    = {38},
  number    = {20},
  pages     = {3782--3790},
  year      = {2019},
  publisher = {Wiley Online Library}
}
@article{FreidlinKorn2019,
  title     = {Methods for accommodating nonproportional hazards in clinical trials: ready for the primary analysis?},
  author    = {Freidlin, Boris and Korn, Edward L},
  journal   = {Journal of Clinical Oncology},
  volume    = {37},
  number    = {35},
  pages     = {3455},
  year      = {2019},
  publisher = {American Society of Clinical Oncology}
}
@article{NPHWG2021Design,
  title     = {Robust design and analysis of clinical trials with non-proportional hazards: a straw man guidance from a cross-pharma working group},
  author    = {Roychoudhury, Satrajit and Anderson, Keaven M and Ye, Jiabu and Mukhopadhyay, Pralay},
  journal   = {Statistics in Biopharmaceutical Research},
  pages     = {1--37},
  year      = {2021},
  publisher = {Taylor \& Francis}
}
@article{HSD,
  title     = {Group sequential designs using a family of type I error probability spending functions},
  author    = {Hwang, Irving K and Shih, Weichung J and De Cani, John S},
  journal   = {Statistics in Medicine},
  volume    = {9},
  number    = {12},
  pages     = {1439--1445},
  year      = {1990},
  publisher = {Wiley Online Library}
}
@article{NPHWG2020sim,
  title     = {Alternative analysis methods for time to event endpoints under nonproportional hazards: a comparative analysis},
  author    = {Lin, Ray S and Lin, Ji and Roychoudhury, Satrajit and Anderson, Keaven M and Hu, Tianle and Huang, Bo and Leon, Larry F and Liao, Jason JZ and Liu, Rong and Luo, Xiaodong and others},
  journal   = {Statistics in Biopharmaceutical Research},
  volume    = {12},
  number    = {2},
  pages     = {187--198},
  year      = {2020},
  publisher = {Taylor \& Francis}
}
@article{MAMS,
  author  = {Pranab Ghosh and Lingyn Liu and P. Senchaudhuri and Ping Gao and Cyrus Mehta},
  title   = {Design and monitoring of multi-arm multi-stage clinical trials},
  journal = {Biometrics},
  year    = {2017},
  doi     = {10.1111/biom.12687}
}
@article{Yung2019,
  title     = {Sample size and power for the weighted log-rank test and Kaplan-Meier based tests with allowance for nonproportional hazards},
  author    = {Yung, Godwin and Liu, Yi},
  journal   = {Biometrics},
  year      = {2019},
  publisher = {Wiley Online Library}
}
@article{AFCAPSdesign,
  title     = {Design \& rationale of the Air Force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS)},
  author    = {Downs, John R and Beere, Polly A and Whitney, Edwin and Clearfield, Michael and Weis, Stephen and Rochen, Jeffrey and Stein, Evan A and Shapiro, Deborah R and Langendorfer, Alexandra and Gotto Jr, Antonio M},
  journal   = {The American Journal of Cardiology},
  volume    = {80},
  number    = {3},
  pages     = {287--293},
  year      = {1997},
  publisher = {Elsevier}
}
@article{AFCAPSresults,
  title     = {Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS},
  author    = {Downs, John R and Clearfield, Michael and Weis, Stephen and Whitney, Edwin and Shapiro, Deborah R and Beere, Polly A and Langendorfer, Alexandra and Stein, Evan A and Kruyer, William and Gotto Jr, Antonio M and others},
  journal   = {Journal of the American Medical Association},
  volume    = {279},
  number    = {20},
  pages     = {1615--1622},
  year      = {1998},
  publisher = {American Medical Association}
}
@article{EXAMINEresults,
  title     = {Alogliptin after acute coronary syndrome in patients with type 2 diabetes},
  author    = {White, William B and Cannon, Christopher P and Heller, Simon R and Nissen, Steven E and Bergenstal, Richard M and Bakris, George L and Perez, Alfonso T and Fleck, Penny R and Mehta, Cyrus R and Kupfer, Stuart and others},
  journal   = {New England Journal of Medicine},
  volume    = {369},
  pages     = {1327--1335},
  year      = {2013},
  publisher = {Mass Medical Soc}
}
@article{EXAMINEdesign,
  title     = {EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome},
  author    = {White, William B and Bakris, George L and Bergenstal, Richard M and Cannon, Christopher P and Cushman, William C and Fleck, Penny and Heller, Simon and Mehta, Cyrus and Nissen, Steven E and Perez, Alfonso and others},
  journal   = {American Heart Journal},
  volume    = {162},
  number    = {4},
  pages     = {620--626},
  year      = {2011},
  publisher = {Elsevier}
}
@misc{hellmann2017estimating,
  title     = {Estimating long-term survival of PD-L1-expressing, previously treated, non-small cell lung cancer patients who received pembrolizumab in KEYNOTE-001 and-010},
  author    = {Hellmann, Matthew David and Ma, Junshui and Garon, Edward B and Hui, Rina and Gandhi, Leena and Soria, Jean-Charles and Anderson, Keaven M and Lubiniecki, Gregory M and Piperdi, Bilal and Herbst, Roy S},
  year      = {2017},
  publisher = {American Society of Clinical Oncology}
}
@article{deCastroGAMLSS,
  title     = {A hands-on approach for fitting long-term survival models under the GAMLSS framework},
  author    = {De Castro, Mario and Cancho, Vicente G and Rodrigues, Josemar},
  journal   = {Computer Methods and Programs in Biomedicine},
  volume    = {97},
  number    = {2},
  pages     = {168--177},
  year      = {2010},
  publisher = {Elsevier}
}
@article{KEYNOTE522,
  title     = {Pembrolizumab for early triple-negative breast cancer},
  author    = {Schmid, Peter and Cortes, Javier and Pusztai, Lajos and McArthur, Heather and K{\"u}mmel, Sherko and Bergh, Jonas and Denkert, Carsten and Park, Yeon Hee and Hui, Rina and Harbeck, Nadia and others},
  journal   = {New England Journal of Medicine},
  volume    = {382},
  number    = {9},
  pages     = {810--821},
  year      = {2020},
  publisher = {Mass Medical Soc}
}
@article{Zeng2006,
  title     = {Semiparametric transformation models for survival data with a cure fraction},
  author    = {Zeng, Donglin and Yin, Guosheng and Ibrahim, Joseph G},
  journal   = {Journal of the American Statistical Association},
  volume    = {101},
  number    = {474},
  pages     = {670--684},
  year      = {2006},
  publisher = {Taylor \& Francis}
}
@article{Zhang2018,
  title     = {Concordance measure and discriminatory accuracy in transformation cure models},
  author    = {Zhang, Yilong and Shao, Yongzhao},
  journal   = {Biostatistics},
  volume    = {19},
  number    = {1},
  pages     = {14--26},
  year      = {2018},
  publisher = {Oxford University Press}
}
<<<<<<< HEAD
@article{AHRKalbfleisch1981,
  title     = {Estimation of the average hazard ratio},
  author    = {Kalbfleisch, John D and Prentice, Ross L},
  journal   = {Biometrika},
  volume    = {68},
  number    = {1},
  pages     = {105--112},
  year      = {1981},
  publisher = {Oxford University Press}
}
@article{AHRRauch2018,
  title     = {The Average Hazard Ratio--A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?},
  author    = {Rauch, Geraldine and Brannath, Werner and Br{\"u}ckner, Matthias and Kieser, Meinhard},
  journal   = {Methods of Information in Medicine},
  volume    = {57},
  number    = {03},
  pages     = {089--100},
  year      = {2018},
  publisher = {Schattauer GmbH}
}
@article{AHRSchemper2009,
  title     = {The estimation of average hazard ratios by weighted Cox regression},
  author    = {Schemper, Michael and Wakounig, Samo and Heinze, Georg},
  journal   = {Statistics in Medicine},
  volume    = {28},
  number    = {19},
  pages     = {2473--2489},
  year      = {2009},
  publisher = {Wiley Online Library}
}
@article{AHRLeon2020,
  title     = {On weighted log-rank combination tests and companion Cox model estimators},
  author    = {Le{\'o}n, Larry F and Lin, Ray and Anderson, Keaven M},
  journal   = {Statistics in Biosciences},
  volume    = {12},
  number    = {2},
  pages     = {225--245},
  year      = {2020},
  publisher = {Springer}
}
=======

@article{yung2019sample,
  title     = {Sample size and power for the weighted log-rank test and Kaplan-Meier based tests with allowance for nonproportional hazards},
  author    = {Yung, Godwin and Liu, Yi},
  journal   = {Biometrics},
  year      = {2019},
  publisher = {Wiley Online Library}
}

@article{lin2020alternative,
  title     = {Alternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis},
  author    = {Lin, Ray S and Lin, Ji and Roychoudhury, Satrajit and Anderson, Keaven M and Hu, Tianle and Huang, Bo and Leon, Larry F and Liao, Jason JZ and Liu, Rong and Luo, Xiaodong and others},
  journal   = {Statistics in Biopharmaceutical Research},
  volume    = {12},
  number    = {2},
  pages     = {187--198},
  year      = {2020},
  publisher = {Taylor \& Francis}
}

@article{magirr2019modestly,
  title     = {Modestly weighted logrank tests},
  author    = {Magirr, Dominic and Burman, Carl-Fredrik},
  journal   = {Statistics in Medicine},
  volume    = {38},
  number    = {20},
  pages     = {3782--3790},
  year      = {2019},
  publisher = {Wiley Online Library}
}

@article{wang2019simulation,
  title   = {A Simulation-free Group Sequential Design with Max-combo Tests in the Presence of Non-proportional Hazards},
  author  = {Wang, Lili and Luo, Xiaodong and Zheng, Cheng},
  journal = {arXiv preprint arXiv:1911.05684},
  year    = {2019}
}

@article{scharfstein1997semiparametric,
  title     = {Semiparametric efficiency and its implication on the design and analysis of group-sequential studies},
  author    = {Scharfstein, Daniel O and Tsiatis, Anastasios A and Robins, James M},
  journal   = {Journal of the American Statistical Association},
  volume    = {92},
  number    = {440},
  pages     = {1342--1350},
  year      = {1997},
  publisher = {Taylor \& Francis Group}
}

@book{tsiatis2007semiparametric,
  title     = {Semiparametric theory and missing data},
  author    = {Tsiatis, Anastasios},
  year      = {2007},
  publisher = {Springer Science \& Business Media}
}

@article{lachin1981introduction,
  title     = {Introduction to sample size determination and power analysis for clinical trials},
  author    = {Lachin, John M},
  journal   = {Controlled Clinical Trials},
  volume    = {2},
  number    = {2},
  pages     = {93--113},
  year      = {1981},
  publisher = {Elsevier}
}

@misc{anderson2009gsdesign,
  title  = {gsDesign: An R Package for Designing Group Sequential Clinical Trials, Version 2.0 Manual},
  author = {Anderson, Keaven M},
  year   = {2009}
}


@article{kim1990study,
  title     = {Study duration for clinical trials with survival response and early stopping rule},
  author    = {Kim, Kyungmann and Tsiatis, Anastasios A},
  journal   = {Biometrics},
  pages     = {81--92},
  year      = {1990},
  publisher = {JSTOR}
}

@article{luo2019design,
  title     = {Design and monitoring of survival trials in complex scenarios},
  author    = {Luo, Xiaodong and Mao, Xuezhou and Chen, Xun and Qiu, Junshan and Bai, Steven and Quan, Hui},
  journal   = {Statistics in Medicine},
  volume    = {38},
  number    = {2},
  pages     = {192--209},
  year      = {2019},
  publisher = {Wiley Online Library}
}

@article{schoenfeld1981asymptotic,
  title     = {The asymptotic properties of nonparametric tests for comparing survival distributions},
  author    = {Schoenfeld, David},
  journal   = {Biometrika},
  volume    = {68},
  number    = {1},
  pages     = {316--319},
  year      = {1981},
  publisher = {Oxford University Press}
}

@article{lu2020statistical,
  title     = {Statistical Considerations for Sequential Analysis of the Restricted Mean Survival Time for Randomized Clinical Trials},
  author    = {Ying Lu and Tian Lu},
  journal   = {Statistics in Biopharmaceutical Research},
  pages     = {1--9},
  year      = {2020},
  publisher = {Taylor \& Francis}
}

@article{luo2019design,
  title     = {Design and monitoring of survival trials based on restricted mean survival times},
  author    = {Luo, Xiaodong and Huang, Bo and Quan, Hui},
  journal   = {Clinical Trials},
  volume    = {16},
  number    = {6},
  pages     = {616--625},
  year      = {2019},
  publisher = {SAGE Publications Sage UK: London, England}
}

@article{lachin2005review,
  title     = {A review of methods for futility stopping based on conditional power},
  author    = {Lachin, John M},
  journal   = {Statistics in Medicine},
  volume    = {24},
  number    = {18},
  pages     = {2747--2764},
  year      = {2005},
  publisher = {Wiley Online Library}
}

@article{wang1987approximately,
  title     = {Approximately optimal one-parameter boundaries for group sequential trials},
  author    = {Wang, Samuel K and Tsiatis, Anastasios A},
  journal   = {Biometrics},
  pages     = {193--199},
  year      = {1987},
  publisher = {JSTOR}
}

@article{pocock1977group,
  title     = {Group sequential methods in the design and analysis of clinical trials},
  author    = {Pocock, Stuart J},
  journal   = {Biometrika},
  volume    = {64},
  number    = {2},
  pages     = {191--199},
  year      = {1977},
  publisher = {Oxford University Press}
}

@article{o1979multiple,
  title     = {A multiple testing procedure for clinical trials},
  author    = {O'Brien, Peter C and Fleming, Thomas R},
  journal   = {Biometrics},
  pages     = {549--556},
  year      = {1979},
  publisher = {JSTOR}
}

@article{haybittle1971repeated,
  title     = {Repeated assessment of results in clinical trials of cancer treatment},
  author    = {Haybittle, JL},
  journal   = {The British journal of radiology},
  volume    = {44},
  number    = {526},
  pages     = {793--797},
  year      = {1971},
  publisher = {The British Institute of Radiology}
}
@article{SludWei,
  title={Two-sample repeated significance tests based on the modified Wilcoxon statistic},
  author={Slud, Eric and Wei, LJ},
  journal={Journal of the American Statistical Association},
  volume={77},
  number={380},
  pages={862--868},
  year={1982},
  publisher={Taylor \& Francis}
}
@article{FHO,
  title={Designs for group sequential tests},
  author={Fleming, Thomas R and Harrington, David P and O'Brien, Peter C},
  journal={Controlled clinical trials},
  volume={5},
  number={4},
  pages={348--361},
  year={1984},
  publisher={Elsevier}
}